Docetaxel with rapid hormonal cycling as a treatment for patients with prostate cancer
Phase of Trial: Phase II
Latest Information Update: 22 Dec 2009
At a glance
- Drugs Docetaxel (Primary) ; Leuprorelin (Primary) ; Testosterone (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 11 Mar 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 16 Oct 2005 New trial record.